Daniel O’Connor
Impact in
- Oncology top 2%
- Cancer-related Molecular Pathways
- Molecular Biology top 5%
- Cell death mechanisms and regulation
- Angiogenesis and VEGF in Cancer
- RNA Interference and Gene Delivery
- Ubiquitin and proteasome pathways
Papers in
-
- Cell death mechanisms and regulation 5
- Angiogenesis and VEGF in Cancer 2
- Oncology 6
- Cancer-related Molecular Pathways 3
- COVID-19 and healthcare impacts 2
- Co-authors
- Dario C. Altieri (6 shared papers)Fengzhi Li (3 shared papers)Nathan R. Wall (3 shared papers)Janet Plescia (3 shared papers)William C. Sessa (2 shared papers)Simona Tognin (2 shared papers)Pier Carlo Marchisio (2 shared papers)David Fulton (1 shared paper)
- Journals
- Journal of Biological Chemistry (2 papers)Molecular Cancer Therapeutics (1 paper)Journal of cardiovascular computed tomography (1 paper)Blood (1 paper)American Heart Journal (1 paper)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Daniel O’Connor
15 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Oncology 996
- Molecular Biology 1.9k
- Cell Biology 394
- Cancer Research 304
- Immunology 356
Countries citing papers authored by Daniel O’Connor
This map shows the geographic impact of Daniel O’Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel O’Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel O’Connor more than expected).
Fields of papers citing papers by Daniel O’Connor
This network shows the impact of papers produced by Daniel O’Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel O’Connor. The network helps show where Daniel O’Connor may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel O’Connor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Regulation of apoptosis at cell division by p34 cdc2 phosphorylation of survivin Hit paper breakdown → | 2000 | 552 |
| 2 | Angiopoietin-1 Inhibits Endothelial Cell Apoptosis via the Akt/Survivin Pathway Hit paper breakdown → | 2000 | 542 |
| 3 | 2000 | 298 | |
| 4 | 2002 | 273 | |
| 5 | 2002 | 265 | |
| 6 | 2020 | 264 | |
| 7 | 2000 | 262 | |
| 8 | Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis. | 2003 | 225 |
| 9 | 2019 | 111 | |
| 10 | 2020 | 11 | |
| 11 | 2024 | 6 | |
| 12 | 2014 | 6 | |
| 13 | 2011 | 2 | |
| 14 | 2013 | 1 | |
| 15 | 2013 | 1 |
About Daniel O’Connor
Daniel O’Connor is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cell Biology and Cardiology and Cardiovascular Medicine, having authored 15 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (5 papers), Microtubule and mitosis dynamics (3 papers), Cancer-related Molecular Pathways (3 papers), Cell Adhesion Molecules Research (2 papers), COVID-19 Clinical Research Studies (2 papers), Angiogenesis and VEGF in Cancer (2 papers), COVID-19 and healthcare impacts (2 papers) and Congenital Heart Disease Studies (2 papers). The work is most often cited by research in Oncology (996 citations), Molecular Biology (1.9k citations), Cell Biology (394 citations), Cancer Research (304 citations) and Immunology (356 citations). Daniel O’Connor has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Dario C. Altieri, Fengzhi Li, Nathan R. Wall, Janet Plescia, William C. Sessa, Simona Tognin, Pier Carlo Marchisio, David Fulton, Andreas Papapetropoulos and Robert G. Kalb. Their work appears in journals such as Journal of Biological Chemistry, Molecular Cancer Therapeutics, Journal of cardiovascular computed tomography, Blood and American Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.